What are common misconceptions patients have about cannabis use in PMR?

PostedFebruary 23, 2026

UpdatedFebruary 23, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Many patients have questions and concerns regarding medical cannabis use for PMR. Understanding cannabis misconceptions in PMR is essential to ensure safe and effective treatment. Misunderstandings often arise from myths about cannabis, widespread misinformation, and skewed public perception of PMR.

Addressing Misconceptions About Cannabis in PMR

Clarifying facts helps patients make informed choices and promotes better outcomes.

Cannabis Causes Severe Addiction

One common myth about cannabis is that it inevitably leads to addiction. While dependency is possible, medical supervision and careful dosing greatly reduce this risk, especially in PMR patients.

Cannabis Provides Instant Relief

Some patients believe cannabis offers immediate symptom relief. Misinformation can create unrealistic expectations, as therapeutic effects often develop gradually and vary with the type, dose, and delivery method.

Cannabis is Unsafe with Other Medications

A frequent cannabis misconception in PMR is that it cannot be combined with other treatments. When monitored by healthcare providers, cannabis can safely complement conventional therapies, though drug interactions should be assessed.

Only Certain Strains Work

Another misunderstanding is that only specific cannabis strains are effective. In reality, individual responses vary, and public perception of PMR often overlooks the benefits of personalised treatment plans.

Recognising and correcting cannabis misconceptions in PMR is critical. Dispelling myths about cannabis, addressing misinformation, and reshaping public perception of PMR enables patients to make informed decisions, improve therapy adherence, and achieve better outcomes with medical cannabis.

If you’re exploring cannabis treatment options for polymyalgia rheumatica, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and polymyalgia rheumatica.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.